TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 46 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $10,000 | -100.0% | 11,000 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $26,105,000 | -16.9% | 23,840,000 | -9.5% | 0.00% | -25.0% |
| Q3 2016 | $31,427,000 | -15.8% | 26,340,000 | -11.5% | 0.00% | -20.0% |
| Q2 2016 | $37,306,000 | +136.2% | 29,770,000 | +145.2% | 0.01% | +150.0% |
| Q1 2016 | $15,797,000 | -15.0% | 12,140,000 | +1.9% | 0.00% | -33.3% |
| Q4 2015 | $18,594,000 | +121.8% | 11,910,000 | +92.7% | 0.00% | +200.0% |
| Q3 2015 | $8,382,000 | +25300.0% | 6,180,000 | +19212.5% | 0.00% | – |
| Q2 2013 | $33,000 | – | 32,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
| Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
| INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
| Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
| MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
| AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |